Here's Why Marinus Pharmaceuticals Stock Is Collapsing Today
Wall Street is not sold on the latest clinical results.
Marinus Pharmaceuticals
MRNS
MRNS
$1.17
$0.06
5.4%
BATS BZX Real Time Price as of August 16, 2019, 4:00 p.m. EDT
View Interactive MRNS Charts
MARINUS PHARMACEUT
News & Analysis: Marinus Pharmaceuticals
Here's Why Marinus Pharmaceuticals Is Sinking Today
A secondary offering on the way isn't what investors wanted to hear.
Here's Why Marinus Pharmaceuticals Inc. Fell as Much as 20.1% Today
The small biopharma announced second-quarter 2018 results and gave a business update.
Here's Why Marinus Pharmaceuticals Rose as Much as 18.4% Today
The tiny biopharma is back on the upswing following an analyst upgrade.
Here's Why Marinus Pharmaceuticals Dropped as Much as 17.7% Today
The biopharma's slide continues -- for good reason this time.
3 Best Healthcare Stocks of 2017
The key to big gains last year? Start off small.
Why Mattel, Marinus Pharmaceuticals, and Northern Dynasty Minerals Slumped Today
Learn why these stocks fell in a strong market.
Here's Why Marinus Pharmaceuticals Is Soaring Today
The tiny yet promising biopharma may be taken more seriously after today.
Here's Why Marinus Pharmaceuticals Rose as Much as 41.1% Thursday
Investors are hoping a competitor's drug will pave the way for the company's own drug.
2 Antidepressant-Focused Biotech Stocks Are Surging Today. Here's Why.
Success for Sage Therapeutics' postpartum depression drug bodes well for a related candidate from Marinus Pharmaceuticals.
